Viewing StudyNCT06590558

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-10-26 @ 3:39 PM
Last Modification Date: 2024-10-26 @ 3:39 PM
Study NCT ID: NCT06590558
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-06
Brief Title: Testing the Addition of an Investigational Anti-Cancer Drug ASTX660 Tolinapant to a Usual Chemotherapy Treatment Eribulin for Treatment of Advanced Triple Negative Breast Cancer
Sponsor: None
Organization: None
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Keywords: